
Overview
Neuca is a listed company and a leader in pharmaceutical wholesale in Poland, supporting independent pharmacies. It also develops a patient-focused business under the Świat Zdrowia brand, covering medical facilities, imaging diagnostics centers and digital tools. The group also expands clinical trials activities and sustainability initiatives.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 57 days early. All were audited by a statutory auditor.
- 202503/06/2026
- 202408/07/2025
- 202305/06/2024
- 202220/06/2023
- 202113/05/2022
- 202006/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 714.00
- High
- PLN 714.00
- Low
- PLN 700.00
- Volume
- 974
- Avg. vol.
- 1.09K
- Market cap
- PLN 3.27B
- P/E ratio
- 16.64
- EPS
- PLN 42.38
- Shares outstanding
- 4.64M
- 52-week
- PLN 678.00 – 714.00
- Dividend yield
- 2.52%
- Dividend
- PLN 17.80
- Ex dividend date
- Jun 29, 2026
- ISIN
- PLTRFRM00018
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 964.59m | USD 17.79m | USD 11.02m |
| Q1 2026 | USD 960.81m | USD 26.12m | USD 18.46m |
| Q4 2025 | USD 884.19m | USD 13.60m | USD 6.81m |
| Q3 2025 | USD 876.15m | USD 19.72m | USD 15.13m |
Results for Q3 2026:Nov 19, 2026
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Wholesale distribution of pharmaceutical products
- Medical care
- Diagnostic imaging
- Clinical trials
Websites
The company has 6 websites. Traffic on the sites is measured with Google Analytics.
- apteline.plLeki, witaminy, suplementy diety, kosmetyki i dermokosmetyki | Apteline.plMagentoGoogle Tag Manager
- aptelink.plOdnajdywanie obszaru głównegoApache
- atechconsulting.plA-TECH Consulting – zarządzanie projektami w budownictwie, nadzór inwestorski, inwestor zastępczy, inspektorApache
Public procurement
1997 tenders recorded as contractor: 571 national ($23,571,596) and 1426 EU ($570,201,701).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 17, 2026 | Supply of various medicines, including programme medicines | –– | Szpital Wojewódzki Im. Jana Pawła II w Bełchatowie | |
| Nov 17, 2026 | Supply of medicines, lot 2 | $4,437$4,437 | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach | |
| Nov 17, 2026 | Supply of medicines, lot 2 | $300.1K$300,069 | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach |
The company is the contractor in 2669 public sector contracts, worth USD 27.50m in total. They were signed with 302 public buyers. The largest number (7) were signed with Uniwersyteckie Centrum Kliniczne.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 16, 2026 | Supply of medicines | $35.81 | Wielkopolskie Centrum Neuropsychiatryczne Im. Oskara Bielawskiego w Kościanie | |
| Nov 15, 2026 | Knitted bandage, Calcium TEVA | $25.40 | Regionalne Centrum Krwiodawstwa I Krwiolecznictwa w Poznaniu | |
| Nov 15, 2026 | Supply of medicines | $53.21 | Regionalny Ośrodek Psychiatrii Sądowej w Starogardzie Gdańskim |
Neuca has been a party to 3 cases before the National Appeal Chamber (since 2018). In 2 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Sep 17, 2024 | Selection of the tender | Upheld | Zespół Zakładów Opieki Zdrowotnej w Ostrowie Wielkopolskim | |
| Feb 23, 2022 | Rejection of the tender | Dismissed | Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Dec 7, 2018 | Error consisting in the tender's non-compliance with the procurement documents | Upheld | Wojewódzki Szpital dla Nerwowo i Psychicznie Chorych w Lubiążu |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2023. In 2026 it is performing 16 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Provision of medical devices | dolnośląskie | 1 | USD 0.00 |
| Provision of medical devices | kujawsko-pomorskie | 1 | USD 0.00 |
| Provision of medical devices | lubelskie | 1 | USD 0.00 |
| Provision of medical devices | lubuskie | 1 | USD 0.00 |
| Provision of medical devices | łódzkie | 1 | USD 0.00 |
Trademarks
The company holds 8 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.
| Mark | Protected until | |
|---|---|---|
| APTELINE ŚWIAT ZDROWIA | Jul 24, 2034 | |
| STACJA FARMACJA PODCAST | Sep 21, 2031 | |
| HeyDoc BLIŻEJ ZDROWIA | Oct 19, 2030 | |
| SUPLINDEX | Jul 29, 2029 | |
| NEUCA Zdrowe Innowacje (word) | Feb 12, 2028 |
Authorized Representatives
Manner of representation
Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to submit declarations of will and represent the company.
Supervisory board
Beneficial owners
Neuca is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Neuca Inwestycje sp. z o.o. | 113,731,320.91 USD | 100% | ||
Świat Zdrowia Operator Medyczny sp. z o.o. | 30,551,053.48 USD | 100% | ||
Neuca Clinical Trials Investments sp. z o.o. | 23,273,906.00 USD | 100% |
Capital group
The company is the parent company of a corporate group. The group has 4 companies, 1 of them abroad.
| Name | Ownership |
|---|---|
| 100% | |
Neuca Clinical Trials Investment Sp. z o.o. | 100% |
| 100% |
Bank accounts
Was a VAT taxpayer from 1994-04-01 to 2024-10-31.
Reason for removal: Art. 96 ust. 7ba (deregistration of a VAT group member upon VAT group registration)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 20, 2023 | Commercial Companies Code notice |
Public aid
5 public aid cases recorded, with a total value of $1,461,886.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 2, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership | |
| May 24, 2021 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| May 24, 2021 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
2 projects recorded: 1 from FE lists ($1,411,569) and 1 Commission grant (FTS) ($0).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-04-01 | Development of a process innovation in the form of a system designed for quality control processes related to the distribution of pharmaceuticals and other medical devices | $1.4M$1,411,569 | Operational Programme Smart Growth | |
| 2018-04-01 | Circularize value chains across european regional innovation strategies | $0$0 | 1.1.31 - Horizon 2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AZ Asset S.A. | $2,606,498,744.35 | farmacol.com.pl | ||
| Polska Grupa Farmaceutyczna S.A. | $1,778,266,449.02 | pgf.com.pl | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex sp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Salus International sp. z o.o. | $538,709,784.11 | salusint.com.pl | ||
| Hurtap S.A. | $480,276,955.20 | hurtap.com.pl | ||
| Medi&More sp. z o.o. | $275,638,188.29 | medi-more.pl | ||
| Novo S.A. | $209,522,261.96 | novo-sa.pl | ||
| Przedsiębiorstwo Zaopatrzenia Aptek Multi Pharme S.A. | $146,864,520.79 | multipharme.pl | ||
| Producencka Centrala Farmaceutyczna Procefar sp. z o.o. | $140,213,508.12 | procefar.pl | ||
| Lubfarm S.A. | $123,208,945.21 | lubfarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-10 | Share capital increase (4,626,044.00 PLN → 4,642,802.00 PLN) | |
| 2026-04-16 | Share capital increase (4,554,344.00 PLN → 4,626,044.00 PLN) | |
| 2025-08-08 | Share capital increase (4,552,744.00 PLN → 4,554,344.00 PLN) | |
| 2025-06-10 | Share capital increase (4,549,444.00 PLN → 4,552,744.00 PLN) | |
| 2025-04-15 | Share capital increase (4,542,304.00 PLN → 4,549,444.00 PLN) |
FAQ
Last updated: 2026-09-10